Steven Etoch

Steven Etoch earned a Bachelor of Science in Business Administration in Finance, with minors in Biology and Management, from the University of Arkansas. He later obtained a Master of Finance degree from Southern Methodist University's Cox School of Business.

Steven Etoch participated in World Series of Poker (WSOP) events between 2005 and 2008. His four WSOP cashes include:

His total WSOP earnings amount to $25,672, with his largest single cash being $12,982 in the 2007 $2,000 No-Limit Hold'em event.

Since October 2018, Steven Etoch has worked as an equity research analyst at Stephens, Inc., a financial services firm. He covers the life science tools and pharma services sector, including companies such as Bio-Techne, Twist Bioscience, Repligen, and BioLife Solutions. As of the search results, he has issued 9 stock ratings, with a success rate of 86% (6 out of 7 ratings profitable) and an average return of 45.7% per rating over a one-year holding period. His best-performing rating was a Buy on Twist Bioscience (TWST) in November 2025, which returned +162.40%.

Steven Etoch's stock coverage focuses on the General sector, primarily in the United States. His rating distribution is 77.78% Buy and 22.22% Hold, with no Sell ratings. He tends to initiate coverage on companies in the life science tools and diagnostics space, often with Buy ratings. His overall analyst ranking places him #2,965 out of 12,314 Wall Street analysts and #6,198 out of 28,910 experts on TipRanks.

While details about Steven Etoch's personal life are limited, his dual career as a poker player and stock analyst highlights a blend of analytical skills and risk assessment. His modest poker earnings and successful analyst track record demonstrate a disciplined approach in both fields. He remains a relatively private figure, with his poker achievements known primarily through WSOP results and his professional reputation built in the finance industry.